SUBSCRIBE
SUBSCRIBE

Septerna, Inc.

NEWS
Business
Top Life Sciences Startups to Watch in 2023
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
December 5, 2022
 · 
15 min read
 · 
BioSpace Editorial Staff
Biotech Bay
Genetown and Biotech Bay Reel in Series A Funds in 2022
After reaching a record high in 2021, venture capital dollars have tailed off in the biopharma industry in 2022. That said, a few biopharma hotbeds have still seen sizeable launch rounds.
November 2, 2022
 · 
5 min read
 · 
Heather McKenzie
IN THE PRESS
Press Releases
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
September 29, 2025
 · 
5 min read
Press Releases
Septerna to Participate in Upcoming September 2025 Investor Conferences
August 28, 2025
 · 
1 min read
Press Releases
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
August 22, 2025
 · 
6 min read
Press Releases
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
August 12, 2025
 · 
10 min read
Press Releases
Septerna to Present at Jefferies Global Healthcare Conference
May 29, 2025
 · 
1 min read
Press Releases
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
May 15, 2025
 · 
10 min read
Press Releases
Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases
May 14, 2025
 · 
6 min read
Press Releases
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
March 28, 2025
 · 
10 min read
Press Releases
Septerna to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
 · 
1 min read
Press Releases
Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
February 18, 2025
 · 
6 min read
Load More
AWARDS
  • NextGen Class of 2023
JOBS